Cargando…
Redox imbalance in COVID-19 pathophysiology
BACKGROUND: The pathophysiologic significance of redox imbalance is unquestionable as numerous reports and topic reviews indicate alterations in redox parameters during corona virus disease 2019 (COVID-19). However, a more comprehensive understanding of redox-related parameters in the context of COV...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464257/ https://www.ncbi.nlm.nih.gov/pubmed/36116160 http://dx.doi.org/10.1016/j.redox.2022.102465 |
_version_ | 1784787544752259072 |
---|---|
author | Majumder, Nairrita Deepak, Vishal Hadique, Sarah Aesoph, Drake Velayutham, Murugesan Ye, Qing Mazumder, Md Habibul Hasan Lewis, Sara E. Kodali, Vamsi Roohollahi, Anthony Guo, Nancy Lan Hu, Gangqing Khramtsov, Valery V. Johnson, Richard J. Wen, Sijin Kelley, Eric E. Hussain, Salik |
author_facet | Majumder, Nairrita Deepak, Vishal Hadique, Sarah Aesoph, Drake Velayutham, Murugesan Ye, Qing Mazumder, Md Habibul Hasan Lewis, Sara E. Kodali, Vamsi Roohollahi, Anthony Guo, Nancy Lan Hu, Gangqing Khramtsov, Valery V. Johnson, Richard J. Wen, Sijin Kelley, Eric E. Hussain, Salik |
author_sort | Majumder, Nairrita |
collection | PubMed |
description | BACKGROUND: The pathophysiologic significance of redox imbalance is unquestionable as numerous reports and topic reviews indicate alterations in redox parameters during corona virus disease 2019 (COVID-19). However, a more comprehensive understanding of redox-related parameters in the context of COVID-19-mediated inflammation and pathophysiology is required. METHODS: COVID-19 subjects (n = 64) and control subjects (n = 19) were enrolled, and blood was drawn within 72 h of diagnosis. Serum multiplex assays and peripheral blood mRNA sequencing was performed. Oxidant/free radical (electron paramagnetic resonance (EPR) spectroscopy, nitrite-nitrate assay) and antioxidant (ferrous reducing ability of serum assay and high-performance liquid chromatography) were performed. Multivariate analyses were performed to evaluate potential of indicated parameters to predict clinical outcome. RESULTS: Significantly greater levels of multiple inflammatory and vascular markers were quantified in the subjects admitted to the ICU compared to non-ICU subjects. Gene set enrichment analyses indicated significant enhancement of oxidant related pathways and biochemical assays confirmed a significant increase in free radical production and uric acid reduction in COVID-19 subjects. Multivariate analyses confirmed a positive association between serum levels of VCAM-1, ICAM-1 and a negative association between the abundance of one electron oxidants (detected by ascorbate radical formation) and mortality in COVID subjects while IL-17c and TSLP levels predicted need for intensive care in COVID-19 subjects. CONCLUSION: Herein we demonstrate a significant redox imbalance during COVID-19 infection affirming the potential for manipulation of oxidative stress pathways as a new therapeutic strategy COVID-19. However, further work is requisite for detailed identification of oxidants (O(2)(•-), H(2)O(2) and/or circulating transition metals such as Fe or Cu) contributing to this imbalance to avoid the repetition of failures using non-specific antioxidant supplementation. |
format | Online Article Text |
id | pubmed-9464257 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-94642572022-09-12 Redox imbalance in COVID-19 pathophysiology Majumder, Nairrita Deepak, Vishal Hadique, Sarah Aesoph, Drake Velayutham, Murugesan Ye, Qing Mazumder, Md Habibul Hasan Lewis, Sara E. Kodali, Vamsi Roohollahi, Anthony Guo, Nancy Lan Hu, Gangqing Khramtsov, Valery V. Johnson, Richard J. Wen, Sijin Kelley, Eric E. Hussain, Salik Redox Biol Research Paper BACKGROUND: The pathophysiologic significance of redox imbalance is unquestionable as numerous reports and topic reviews indicate alterations in redox parameters during corona virus disease 2019 (COVID-19). However, a more comprehensive understanding of redox-related parameters in the context of COVID-19-mediated inflammation and pathophysiology is required. METHODS: COVID-19 subjects (n = 64) and control subjects (n = 19) were enrolled, and blood was drawn within 72 h of diagnosis. Serum multiplex assays and peripheral blood mRNA sequencing was performed. Oxidant/free radical (electron paramagnetic resonance (EPR) spectroscopy, nitrite-nitrate assay) and antioxidant (ferrous reducing ability of serum assay and high-performance liquid chromatography) were performed. Multivariate analyses were performed to evaluate potential of indicated parameters to predict clinical outcome. RESULTS: Significantly greater levels of multiple inflammatory and vascular markers were quantified in the subjects admitted to the ICU compared to non-ICU subjects. Gene set enrichment analyses indicated significant enhancement of oxidant related pathways and biochemical assays confirmed a significant increase in free radical production and uric acid reduction in COVID-19 subjects. Multivariate analyses confirmed a positive association between serum levels of VCAM-1, ICAM-1 and a negative association between the abundance of one electron oxidants (detected by ascorbate radical formation) and mortality in COVID subjects while IL-17c and TSLP levels predicted need for intensive care in COVID-19 subjects. CONCLUSION: Herein we demonstrate a significant redox imbalance during COVID-19 infection affirming the potential for manipulation of oxidative stress pathways as a new therapeutic strategy COVID-19. However, further work is requisite for detailed identification of oxidants (O(2)(•-), H(2)O(2) and/or circulating transition metals such as Fe or Cu) contributing to this imbalance to avoid the repetition of failures using non-specific antioxidant supplementation. Elsevier 2022-09-11 /pmc/articles/PMC9464257/ /pubmed/36116160 http://dx.doi.org/10.1016/j.redox.2022.102465 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Research Paper Majumder, Nairrita Deepak, Vishal Hadique, Sarah Aesoph, Drake Velayutham, Murugesan Ye, Qing Mazumder, Md Habibul Hasan Lewis, Sara E. Kodali, Vamsi Roohollahi, Anthony Guo, Nancy Lan Hu, Gangqing Khramtsov, Valery V. Johnson, Richard J. Wen, Sijin Kelley, Eric E. Hussain, Salik Redox imbalance in COVID-19 pathophysiology |
title | Redox imbalance in COVID-19 pathophysiology |
title_full | Redox imbalance in COVID-19 pathophysiology |
title_fullStr | Redox imbalance in COVID-19 pathophysiology |
title_full_unstemmed | Redox imbalance in COVID-19 pathophysiology |
title_short | Redox imbalance in COVID-19 pathophysiology |
title_sort | redox imbalance in covid-19 pathophysiology |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464257/ https://www.ncbi.nlm.nih.gov/pubmed/36116160 http://dx.doi.org/10.1016/j.redox.2022.102465 |
work_keys_str_mv | AT majumdernairrita redoximbalanceincovid19pathophysiology AT deepakvishal redoximbalanceincovid19pathophysiology AT hadiquesarah redoximbalanceincovid19pathophysiology AT aesophdrake redoximbalanceincovid19pathophysiology AT velayuthammurugesan redoximbalanceincovid19pathophysiology AT yeqing redoximbalanceincovid19pathophysiology AT mazumdermdhabibulhasan redoximbalanceincovid19pathophysiology AT lewissarae redoximbalanceincovid19pathophysiology AT kodalivamsi redoximbalanceincovid19pathophysiology AT roohollahianthony redoximbalanceincovid19pathophysiology AT guonancylan redoximbalanceincovid19pathophysiology AT hugangqing redoximbalanceincovid19pathophysiology AT khramtsovvaleryv redoximbalanceincovid19pathophysiology AT johnsonrichardj redoximbalanceincovid19pathophysiology AT wensijin redoximbalanceincovid19pathophysiology AT kelleyerice redoximbalanceincovid19pathophysiology AT hussainsalik redoximbalanceincovid19pathophysiology |